Can expanding #DigitalHealth globally prevent future pandemics? WHO and the European Commission are moving this month to “offer all WHO Member States access to an open-source digital health tool” under a new Global Digital Health Certification Network: ow.ly/lNyp50OI42v

#DIA2023 is coming to Boston June 25-29, and we’re proudly returning to exhibit in our home city! Join us at booth #317 to meet the team and learn how CSOFT is leading translation and localization solutions for global drug development. Our post has more: ow.ly/yGy850Oy2TO

As in translation, one edit can make all the difference when it comes to genomes. Reuters reports Novo Nordisk is collaborating with NC-based Life Edit Therapeutics to target point mutations, the single-letter genetic errors behind some genetic diseases: ow.ly/X6HE50OvY4h

A new Reuters report identifies “jump zones” with increased risk of bat-to-human virus transmission in 113 countries across the globe, highlighting a vast need for #immunology #translations to drive research on the prevention and containment of outbreaks: ow.ly/XImX50OqoN7

It’s finally over, but the pandemic’s lessons for multilingual communications continue. Our latest post looks at findings that patients’ access to accurate, culturally considerate information in their languages may have cut illness and death rates by ~50%: ow.ly/qYC650Oo5A3

Japan’s Otsuka Pharmaceutical Co has gained FDA approval for Rexulti to relieve symptoms of agitation common in #Alzheimer’s patients, the first of its kind available in the US, where the molecule was previously approved in mental health treatment: ow.ly/oFKL50OlIYN

Could a shot against #LymeDisease be the next billion-dollar travel #vaccine? French #pharmaceutical Valneva is starting the phase 3 trial of its VLA15 vaccine, aiming to fight rising infection rates as Lyme-carrying ticks migrate to more regions globally: ow.ly/qRIz50Oju4X

CSOFT Health Sciences is happily celebrating a great week in Barcelona for Outsourcing In Clinical Trials Europe 2023, where we were able to meet new and familiar faces in the #CRO sphere to explore collaborative opportunities in #localization. More here: ow.ly/NAFj50OhiF0

Hey, #ClinicalTrials professionals! CSOFT HS is in Barcelona for Outsourcing in Clinical Trials Europe 2023 today & tomorrow (May 3rd &4th): ow.ly/KKBK50OecVH. Let’s talk about how we can help elevate your multilingual communications strategy! #OCTEurope2023 #Barcelona

As more medical devices overlap with #MedTech tools, localizing either product class demands a strong familiarity with the other and its criteria for translation. Our post explores how an ISO 13485:2016-certified #translation partner like CSOFT can help: ow.ly/K04150O68GX

A large-scale Eli Lilly trial found Mounjaro, previously FDA-approved for #diabetes, helped obese diabetic participants reduce their body weight by an unprecedented 16% (34 lbs. on average), setting the stage for reapproval as a weight loss treatment: ow.ly/4m0u50NXQ40

WHO’s newly launched Health Inequality Data Repository database covers more than 2000 measures of 11 million datapoints on health care quality and access worldwide, highlighting both substantial progress and persistent challenges: ow.ly/SkAZ50NRwe9

Together with Afrigen Biologics and Biovac, #WHO is expanding vaccine access for lower-income countries with its new mRNA technology hub in Cape Town, launching today. #Vaccine candidate AfriVac 2021 would be the first of its kind developed in Africa: ow.ly/iZF650NO04E

How do CSOFT Health Sciences’ medical translations help life science companies integrate the regulatory best practices and patient-centric language essential to effective #pharmaceutical labeling? Our newest white paper explores: ow.ly/TB3I50Nwb6a #Medical #Translations

When conducting #ClinicalTrials in Europe and around the world, accurate and effective IVD translations help mitigate clinical trial delays that stand in the way of device approval. Read our blog for more: ow.ly/fTHP50Nrvyj #IVD #Translations

Following the premiere of Bioethics International’s new #diversity index in 2023, how can clinical trial translations improve a company’s future rating? Read about improving transparency and representativeness on our blog: ow.ly/fkgy50NfzmP #ClinicalTrial #Translations

Pharmaceutical labeling translations that understand not just regional regulatory guidelines but also patient-centric communication are essential for any global pharmaceutical company. Read our most recent blog: ow.ly/Z0pw50N0V5X #Pharmaceutical #Labeling #Translations

Generative AI #ChatGPT has taken communication and translation-heavy industries by storm – but in the highly regulated field that is human health, where do ChatGPT translations fit into healthcare? Read our most recent blog: ow.ly/IibQ50MPPUJ #Medical #Translations

In our latest Clinical Trial Corner post, Dr. Vladimir Misik discusses the socioeconomic value of industry clinical trials not only for patients, but also across many sectors in participating countries. Read the blog here: ow.ly/Shje50LWlRc #ClinicalTrials #Pharmaceuticals

Patient-reported outcome (PRO) translations have long required linguistic validation, so with the rise of decentralized #ClinicalTrials, what additional considerations are there for electronic PRO (ePRO) #translations? Read our newest blog for more: ow.ly/5wg950MBfHG